The FDA hasn’t approved a medical drug for weight loss in 13 years. Now we have a few, and the first one available is called Qsymia.
Qsymia is a combination of a long time seizure medication topiramate and a long term appetite suppressant phentermine.
The company making this drug has completed trials on more than 3,700 patients. Patients taking Qsymia were able to achieve an average weight loss of 10% in ” obese” (BMI greater than 30) patients when used in conjunction with diet, exercise and a lifestyle modification program. If you do not lose at least 5% of your original weight after 24 weeks of treatment it is recommended Qsymia be discontinued because it will not work for you.
Qsymia is indicated for patients with a BMI of 30 or greater, or 27 or greater in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes or high cholesterol.
If you are thinking about getting pregnant, want to get pregnant or are not using birth control DO NOT USE THIS MEDICATION!!! It can cause fetal harm. Qsymia is not recommended if you have glaucoma, hyperthyroidism, use manoamine oxidase inhibitors (MAOIs) or have a known hypersensitivity or idiosyncrasy to the sympathomimetic amines.
The dosing of Qsymia changes after the first 14 days and possibly after the first 12 weeks. Qsymia is available only through certified mail order pharmacies so a prescription is required.
Further details may be found at www.qsymia.com.
We are excited to offer this medication to our patients. It will be most successful if combined with a “High Accountability” four or eight week shake/shot program. We will monitor possible side effects and help to get you back on track with a diet, exercise, and lifestyle modification program with a proven success rate.
DO NOT get this medication confused with BELVIQ. Belviq is expected to be released at the beginning of next year. It is expected to be similar to “Fen-Phen” without the heart valve complications.
Please call us at 800 633-3300 if you have further questions. Our goal is to keep our patients informed!